TechCrunch Startup News Level Zero Health banks $6.9M to prove wearable medtech can take the strain out of hormone testing
7 snips
Feb 20, 2025 A pioneering female-founded startup has secured $6.9 million in funding to develop a revolutionary wearable device for continuous hormone monitoring. This innovation aims to enhance women's health through non-invasive technology while tackling the challenges of regulatory approval. With a focus on improving hormone testing accuracy, the company is poised to make significant advancements in diagnostics for both men and women, marking a new era in medtech solutions.
AI Snips
Chapters
Transcript
Episode notes
Disrupting Hormone Monitoring
- Level Zero Health, a female-founded startup, secured $6.9M in pre-seed funding to develop a continuous hormone monitoring device.
- This innovation aims to create a new market, similar to how continuous glucose monitors (CGMs) revolutionized diabetes care.
Bridging the Gap
- Developing a novel medical device like this takes time, especially given the hardware and regulatory hurdles.
- The company is working on a simpler, single-use product for intermittent hormone testing to bridge the gap.
The Power of Interstitial Fluid
- The device uses tiny needles to sample interstitial fluid, which contains biochemical compounds also found in blood.
- Continuous monitoring could transform our understanding of hormones, similar to how CGMs impacted diabetes management.